BioSpace News Archive

GlucoTrack, Inc., a medical device and digital health platform company focused on diabetes and prediabetes, announced that it intends to offer shares of common stock in a firm commitment underwritten public offering.

Bridge Biotherapeutics (KQ288330) announced it has dosed the first patient in its Phase 2a clinical study to evaluate the efficacy, safety, and tolerability of BBT-877 in patients with idiopathic pulmonary fibrosis (IPF).

A landmark paper published today in The Lancet Neurology journal by leaders of the Parkinson’s Progression Markers Initiative (PPMI) confirms the most significant breakthrough yet in the search for a Parkinson’s biomarker: a biological test for Parkinson’s disease that demonstrates high diagnostic accuracy, differentiates molecular subtypes and detects disease in individuals before cardinal movement symptoms arise.

With an increasing number of scientists raising their concerns over research on exotic viruses worldwide and the debate on SARS-CoV-2’s origin still raging, AIDS Healthcare Foundation (AHF) urges all countries to promote international transparency and strict oversight on work with highly-contagious, pandemic-capable viruses.

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced its participation at two upcoming investor conferences:

MIM Software Inc. is proud to support the efforts of the Melbourne Theronastic Innovation Centre (MTIC) in Melbourne, Victoria as they launch the use of the Siemens Biograph Vision Quadra PET/CT, one of the few such “all-organ” scanners in the world.